Involvement of Rho-kinase in agonists-induced contractions of arteriosclerotic human arteries

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 2, 2002, Pages 243-248

  Kandabashi, Tadashi ^a   Shimokawa, Hiroaki ^a   Mukai, Yasushi ^a   Matoba, Tetsuya ^a   Kunihiro, Ikuko ^a   Morikawa, Keiko ^a   Ito, Masaaki ^a   Takahashi, Shosuke ^a   Kaibuchi, Kozo ^a   Takeshita, Akira ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Human artery; Rho kinase; Signal transduction; Vascular smooth muscle

Indexed keywords

FASUDIL; RHO KINASE; SEROTONIN;

ARTERIOSCLEROSIS; ARTERY CONSTRICTION; ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY SPASM; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; PATHOGENESIS; PHOSPHORYLATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; CORONARY ARTERIOSCLEROSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HISTAMINE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MUSCLE PROTEINS; MUSCLE, SMOOTH, VASCULAR; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; SEROTONIN; SUCCINATES; THORACIC ARTERIES; VASOCONSTRICTION; VASODILATOR AGENTS;

EID: 0036164704     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/hq0202.104274     Document Type: Article

References (35)

1. "Variant" angina: One aspect of a continuous spectrum of vasospastic myocardial ischemia: Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients
2. Coronary-artery spasm
3. Spasm of the coronary arteries: Causes and consequences (the scientist's viewpoint)
4. The pathogenesis of coronary artery disease and the acute coronary syndromes
5. Cellular and molecular mechanisms of coronary artery spasm: Lessons from animal models
6. Regulation of smooth muscle contractile elements by second messengers
7. Signal transduction and regulation in smooth muscle
8. What is special about smooth muscle? The significance of covalent crossbridge regulation
9. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase)
10. A novel serine-threonine kinase binding the Ras-related RhoA GTPase which translocates the kinase to peripheral membranes
11. The small GTP-binding protein Rho binds to activates a 160 kDa Ser/Thr protein kinase homologous to myotonic dystrophy kinase
12. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells
13. A novel protein phosphatase-1 inhibitory protein potentiated by protein kinase C: Isolation from porcine aorta media and characterization
14. Phosphorylation of CPI-17, an inhibitory phosphoprotein of smooth muscle myosin phosphatase, by Rho-kinase
15. 2+ sensitization in triton X-100-demembranated rabbit arterial smooth muscle
16. Chronic treatment with interleukin-1β induces coronary intimal lesions and vasospastic responses in pigs in vivo: The role of platelet-derived growth factor
17. Tyrosine kinase inhibitor suppresses coronary arteriosclerotic changes and vasospastic responses induced by chronic treatment with interleukin-1β in pigs in vivo
18. Coronary artery spasm does not depend on the intracellular calcium store but is substantially mediated by the protein kinase C-mediated pathway in a swine model with interleukin-1β in vivo
19. Vasculoprotective role of inducible nitric oxide synthase at inflammatory coronary lesions induced by chronic treatment with interleukin-1β in pigs in vivo
20. Enhanced myosin light chain phosphorylations as a central mechanism for coronary artery spasm in a swine model with interleukin-1β
21. Rhokinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm
22. Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin- 1β
23. Adenovirus-mediated transfer of dominant-negative Rho-kinase induces a regression of coronary arteriosclerosis in pigs in vivo
24. Long-term inhibition of Rho-kinase induces a regression of arteriosclerotic coronary lesions in a porcine model in vivo
25. Phosphorylation of myosin-binding subunit (MBS) of myosin phosphatase by Rho-kinase in vivo
26. Phosphorylation of the 20,000-dalton light chain of smooth muscle myosin by the calcium-activated, phospholipid-dependent protein kinase: Phosphorylation sites and effects of phosphorylation
27. Myosin light chain diphosphorylation is enhanced by growth promotion of cultured smooth muscle cells
28. Rho-kinase inhibitors prevent agonist-induced vasospasm in human internal mammary artery
29. Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility
30. Histamine-induced vasoconstriction involves phosphorylation of a specific inhibitor protein for myosin phosphatase, by protein kinase C alpha and delta isoforms
31. Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans
32. Rho-kinase inhibitor suppresses coronary artery spasm in humans
33. Rho-kinase is involved in macrophage-mediated formation of coronary vascular lesions in pigs in vivo
34. Gene transfer of dominant negative Rho-kinase suppresses neointimal formation after balloon injury in pigs
35. Involvement of Rho-kinase in hypertensive vascular disease: A novel therapeutic target in hypertension